Start-ups: Busting dumb myths

There are many myths and taboos attached to the start-up world. Some maybe quite real to a certain extent but some are utterly nonsensical. Often times much stereotypical beliefs float around which are not even to the slightest proximity to reality.

busted

Investors, venture capitalists, financial institutions, incubators and everybody who are a part of the start-up scene have believed, and still believe many myths surrounding start-ups.

BioSpectrum's Raj Gunashekar spoke to some of the leading Life Sciences start-ups in the country to do a reality check, and bust long-held dumb myths about Life Sciences start-ups. Here we go:

Myth #1: Biotech start-ups struggle with fundraising

Venture capitalist fundraising is difficult irrespective of the sector. "With a good product and a great team backing it, you become an attractive incubation target. There are a number of 'healthcare only' funds made available for life science start-ups," says Dr Mallik Sundaram, co-founder of Mitra Biotech.

Investors shy away from Life Sciences start-ups because of the widespread notion that investments in this field are risky with long gestation periods.

 

Previous 1 3 4 5 6 7 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X